DV Medical Supply, Inc.

2000 W 135th Street
Gardena, CA. 90249
US

800-438-2568

Nobivac Canine 3-DAPv 1mL 25/Doses (EXP 01/09/21)
Nobivac Canine 3-DAPv 1mL 25/Doses (EXP 01/09/21)

Nobivac Canine 3-DAPv 1mL 25/Doses (EXP 01/09/21)

In Stock.
Part Number:DVM-107097P-SD
  • Disclaimer:This product requires special handling and is shipped overnight delivery. Customer assumes responsibility if the package is undeliverable for any reason. Address verification and business hours of operation for package receipt is the responsibility of the customer.
MPN: 006772
Manufacturer: Merck Animal Health USA
You need to have an approved DV Med account to order this product.

CANINE 3-DAPV PROVIDES PROVEN PROTECTION FOR DOGS

Canine Distemper Virus, Canine Adenovirus 2, Canine Parvovirus (modified live viruses).
  • Provides broad coverage against canine distemper virus, canine adenovirus type 2 (CAV-2), and canine parvovirus (CPV)
  • Challenge studies in dogs showed 100% protection over 3 years against distemper, adenovirus type 1, and parvovirus10
  • Formulation containing CPV STRAIN 154®, able to override maternal antibodies at an early age1
  • Serologic tests demonstrated high antibody titers throughout the 3-year post-vaccination isolation period10
  • Manhattan strain of CAV-2 was used to confer protection against canine infectious hepatitis caused by canine adenovirus type 1 (CAV-1) without eliciting the adverse reactions associated with CAV-1 vaccines10
  • Protects against the commonly spread canine distemper virus
  • Protects against all field strains of CPV currently seen2
  • Prevents both infectious canine hepatitis caused by CAV-1 and infectious tracheobronchitis associated with CAV-2
INDICATIONS:
Approved for the vaccination of healthy dogs for the prevention of disease caused by canine distemper virus and canine parvovirus, and as an aid in the prevention of disease caused by canine adenovirus (both infectious canine hepatitis and infectious tracheobronchitis) for up to 3 years following initial and booster vaccinations.
Recommended for use in healthy dogs 7 weeks of age or older.

CANINE 3-DAPV IS A SAFE CHOICE
  • Can be safely administered to dogs as young as 7 weeks of age
  • High-titer CPV and canine distemper virus strains proven safe for dogs as young as 4 weeks of age1
  • No injection site or vaccine-related reactions reported during challenge studies

ADMINISTRATION AND DOSAGE
  • Initial 1 mL dose given by subcutaneous route to healthy dogs as early as 7 weeks of age
  • 1 mL booster doses given every 3 to 4 weeks until 12 weeks of age
  • Dogs over 12 weeks of age should initially receive 2 doses 3–4 weeks apart
  • Revaccination every 3 years with a single dose thereafter
  • Available in a 25 x 1 mL dose presentation

Related Items